Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) created an exceptional situation in which numerous laboratories in Europe simultaneously implemented SARS-CoV-2 diagnostics. These laboratories reported in February 2020 that commercial primer and probe batches for SARS-Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Mögling, Ramona, Meijer, Adam, Berginc, Natasa, Bruisten, Sylvia, Charrel, Remi, Coutard, Bruno, Eckerle, Isabella, Enouf, Vincent, Hungnes, Olav, Korukluoglu, Gülay, Kossyvakis, Thanos, Mentis, Andreas, Molenkamp, Richard, Muradrasoli, Shaman, Papa, Anna, Pigny, Fiona, Thirion, Laurence, van der Werf, Sylvie, Reusken, Chantal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392437/
https://www.ncbi.nlm.nih.gov/pubmed/32433015
http://dx.doi.org/10.3201/eid2608.201843
Descripción
Sumario:The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) created an exceptional situation in which numerous laboratories in Europe simultaneously implemented SARS-CoV-2 diagnostics. These laboratories reported in February 2020 that commercial primer and probe batches for SARS-CoV-2 detection were contaminated with synthetic control material, causing delays of regional testing roll-out in various countries.

Ejemplares similares